Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last C$0.09 CAD
Change Today 0.00 / 0.00%
Volume 1.0K
DMA On Other Exchanges
Symbol
Exchange
Berlin
Venture
OTC US
As of 9:30 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

diamedica inc (DMA) Snapshot

Open
C$0.09
Previous Close
C$0.09
Day High
C$0.09
Day Low
C$0.09
52 Week High
11/11/14 - C$0.75
52 Week Low
12/2/14 - C$0.04
Market Cap
7.0M
Average Volume 10 Days
75.4K
EPS TTM
C$-0.07
Shares Outstanding
77.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for DIAMEDICA INC (DMA)

Related News

No related news articles were found.

diamedica inc (DMA) Related Businessweek News

No Related Businessweek News Found

diamedica inc (DMA) Details

DiaMedica Inc., a development stage biopharmaceutical company, engages in the discovery and development of drugs for the treatment of acute vascular disease of the brain, kidney, and heart. The company’s lead product is DM199, a recombinant human tissue kallikrein-1 protein with a focus on type 2 diabetes and acute vascular diseases, such as acute ischemic stroke. It also develops DMDx, a companion diagnostic in vitro assay for kidney disease. The company was formerly known as Diabex Inc. and changed its name to DiaMedica Inc. in February 2001. DiaMedica Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

3 Employees
Last Reported Date: 04/30/15
Founded in 2000

diamedica inc (DMA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: C$276.5K
Consulting Chief Medical Officer
Total Annual Compensation: C$11.8K
Vice-President of Research
Total Annual Compensation: C$177.0K
Compensation as of Fiscal Year 2013.

diamedica inc (DMA) Key Developments

Diamedica Inc. Presents at 5th LD Micro Invitational Conference, Jun-01-2015 10:30 AM

Diamedica Inc. Presents at 5th LD Micro Invitational Conference, Jun-01-2015 10:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Blvd, Los Angeles, CA 90049, United States. Speakers: Rick Pauls, Chief Executive Officer, President and Director.

Diamedica Inc. Presents at Equities.com Small-Cap Stars Spring Conference, Jun-10-2015

Diamedica Inc. Presents at Equities.com Small-Cap Stars Spring Conference, Jun-10-2015 . Venue: Convene Times Square, New York, New York, United States.

Diamedica Inc. Auditor Raises 'Going Concern' Doubt

Diamedica Inc. filed its Annual on Apr 30, 2015 for the period ending Dec 31, 2014. In this report its auditor, KPMG LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DMA:CN C$0.09 CAD 0.00

DMA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for DMA.
View Industry Companies
 

Industry Analysis

DMA

Industry Average

Valuation DMA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIAMEDICA INC, please visit www.diamedica.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.